High rates of chronic hepatitis b and tuberculosis co-infection observed in nationally representative quest diagnostics study

Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis b, despite similar risk factors in patients findings heighten caution about use of tuberculosis therapies, which raise risk of liver injury in patients co-infected with chronic hepatitis b virus secaucus, n.j. , july 25, 2022 /prnewswire/ -- concurrent testing for chronic hepatitis b (hbv) and tuberculosis (tb) occurs in a minority of patients who test positive for either condition, despite similar risk profiles and, for some, risk of tb therapy-induced liver damage, according to a new quest diagnostics health trends® study published in the journal of public health management & practice.
DGX Ratings Summary
DGX Quant Ranking